Cargando…
Leukoreduced blood components: Advantages and strategies for its implementation in developing countries
Removal of leucocytes from various blood products has been shown to minimize Febrile nonhemolytic transfusion reactions, HLA alloimmunization, platelet refractoriness in multitransfused patients and prevention of transmission of leukotropic viruses such as EBV and CMV. Rapidly growing size of hemato...
Autores principales: | Sharma, R. R., Marwaha, Neelam |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847337/ https://www.ncbi.nlm.nih.gov/pubmed/20376259 http://dx.doi.org/10.4103/0973-6247.59384 |
Ejemplares similares
-
Association of CTLA4 Gene Polymorphism with Transfusion Reaction after Infusion of Leukoreduced Blood Component
por: Wen, Ying-Hao, et al.
Publicado: (2019) -
The Influence of CD28 Gene Polymorphism in Transfusion Reaction after Transfusing Leukoreduced Blood Components
por: Chen, Ding-Ping, et al.
Publicado: (2020) -
Microcirculation and blood transfusions during sepsis: leukoreduced (LR) versus non-LR red blood cells
por: Donati, A, et al.
Publicado: (2013) -
Use of Leukoreduced Blood Does Not Reduce Infection, Organ Failure, or Mortality Following Trauma
por: Englehart, Michael S., et al.
Publicado: (2009) -
Hemolysis of irradiated leukoreduced red blood cells during rapid warming: An in vitro experimental study
por: Lee, Sukyung, et al.
Publicado: (2015)